PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4
Year: 2018
Type: article
Abstract: The differentiation status of neuroblastoma (NB) strongly correlates with its clinical outcomes; however, the molecular mechanisms driving maintenance of stemness and differentiation remain poorly understood. Here, we show that plant homeodomain finger-containing protein 20 (PHF20) functions as a critical epigenetic regulator in sustaining stem cell-like phenotype of NB by using CRISPR/Cas9-based targeted knockout (KO) for high-throughput screening of gene function in NB cell differentiation. The expression of PHF20 in NB was significantly associated with high aggressiveness of the tumor and poor outcomes for NB patients. Deletion of PHF20 inhibited NB cell proliferation, invasive migration, and stem cell-like traits. Mechanistically, PHF20 interacts with poly(ADP-ribose) polymerase 1 (PARP1) and directly binds to promoter regions of octamer-binding transcription factor 4 (OCT4) and sex determining region Y-box 2 (SOX2) to modulate a histone mark associated with active transcription, trimethylation of lysine 4 on histone H3 protein subunit (H3K4me3). Overexpression of OCT4 and SOX2 restored growth and progression of PHF20 KO tumor cells. Consistently, OCT4 and SOX2 protein levels in clinical NB specimens were positively correlated with PHF20 expression. Our results establish PHF20 as a key driver of NB stem cell-like properties and aggressive behaviors, with implications for prognosis and therapy.
DOI: 10.1093/jmcb/mjy007
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Cancer Prevention and Research Institute of Texas, Ohio Department of Development, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, National Institutes of Health, Houston Methodist Research Institute, National Key Research and Development Program of China, National Cancer Institute
Awards: CPRIT Core for RNA Therapeutics and Research, G4494052074, G5738746933, Identification of novel immune targets and neoantigens for development of immunotherapy for breast cancer, G5989595523, G6636714046, G7694331032, Immunotherapy targeting triple negative breast cancer using NY-ESO-1-specific TCRs and blockade of immune suppression, G8546168071, G8944795983
OpenAlex ID: W2791224813
